ABIVAX Soci?t? Anonyme - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABVX Nasdaq 2836 www.abivax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ABIVAX Soci?t? Anonyme

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod - Jul 30th, 2026 2:05 pm
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight - Jul 30th, 2026 8:31 am
PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants - Jul 29th, 2026 1:00 am
ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In? - Jul 26th, 2026 2:07 am
Abivax (ENXTPA:ABVX) Adds Commercial Leaders And Signs Valerio R And D Deal - Jul 25th, 2026 4:07 am
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments - Jul 23rd, 2026 2:05 pm
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update - Jul 16th, 2026 1:07 am
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross? - Jul 10th, 2026 7:55 am
Abivax CEO says $920M raise funds U.S. drug launch without Big Pharma - Jul 10th, 2026 7:35 am
3 Soaring Stocks That May Have More Upside Ahead - Jul 7th, 2026 5:35 pm
Abivax: Wall Street Catches Up to the Data - Jul 7th, 2026 10:25 am
Abivax Announces Closing of $920 Million Public Offering - Jul 6th, 2026 2:05 pm
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says - Jul 6th, 2026 9:12 am
Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now? - Jul 3rd, 2026 5:32 pm
ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds - Jul 2nd, 2026 4:30 am
Abivax jumps as fully exercised option lifts share-sale haul to $920 million - Jul 2nd, 2026 2:20 am
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) - Jul 2nd, 2026 12:00 am
ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress - Jul 1st, 2026 4:14 pm
Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease - Jul 1st, 2026 10:00 am
Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures - Jul 1st, 2026 8:23 am